Source: International Congress 2014 – Asthma and COPD devices and treatments
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Van Holsbeke, J. Marshall, J. De Backer, W. Vos (Kontich, Belgium; Cambridge, United Kingdom). Median mass aerodynamic diameter (MMAD) and fine particle fraction (FPF): Influence on lung deposition?. Eur Respir J 2014; 44: Suppl. 58, 912

Member's Comments

No comment yet.

Related content which might interest you: Comparison of the particle size distribution of fluticasone propionate/formoterol and beclometasone/formoterol MDI using laser diffraction Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 Are ultrafine particle inhalers, better for patients with small airway involvement? Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 Number of particles in exhaled air is decreased by broncho-constriction Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Are extra-fine particles from dry powder inhalers likely to improve lung deposition? Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 In vitro analysis of two formulations of fluticasone/ salmeterol pMDI for delivered dose uniformity and aerodynamic particle size distribution Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 The effect of inhalation duration on lung deposition with a pressurized metered-dose inhaler (pMDI) Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 Drug particle size and lung deposition in COPD Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 LATE-BREAKING ABSTRACT: Tomoscintigraphic comparison of lung deposition with a vibrating-mesh and a jet nebulizer Source: International Congress 2015 – A more functional view of chest pathology Year: 2015 Calculation of peripheral airspace dimensions from deposition of inhaled nanoparticles Source: International Congress 2016 – Monitoring airway diseases with different tools Year: 2016 Late Breaking Abstract - Lung deposition of two different ICS/LABA combinations with Dry Powder Inhaler (DPI) in asthmatic patients using Functional Respiratory Imaging (FRI). Source: International Congress 2019 – Imaging for prognostication and disease characterisation: 2019 update Year: 2019 Delivery of medication by breath-actuated nebulizer (BAN) is similar when used with differing inhalation / exhalation ratios: A contrast to breath enhanced nebulizer (BEN) behavior Source: International Congress 2014 – Respiratory symptoms in primary care populations Year: 2014 Deposition of inhaled nanoparticles, airflow obstruction and emphysema Source: International Congress 2016 – Pulmonary drug delivery Year: 2016 The amount of endogenous particles in exhaled air is correlated to peripheral airway obstruction Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Optimization of inhalation treatment – Evaluation of influence of spacer integrated with the spirometer on aerosol particle distribution from pMDI-EB Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I Year: 2010 Effects of forced exhalations and cough on surfactant content and size distribution of exhaled particles Source: International Congress 2016 – Lung function and imaging: new findings and new approaches Year: 2016 LATE-BREAKING ABSTRACT: Effect of inhalation profiles and throat geometries on predicted lung deposition of budesonide and formoterol (BF) when inhaled through two different devices Source: International Congress 2014 – Innovative technology and techniques in respiratory function Year: 2014 Dose-response effect of small particle vs standard size particle inhaled corticosteroids on severe asthma exacerbations by sex Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care Year: 2015 The performance of a new vibrating mesh prototype nebulizer for inhaled biodrugs Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 In vitro lung deposition of fluticasone propionate/formoterol (FP/FORM) pressurized metered dose inhaler (pMDI) with different inhalation profiles Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 Association between body mass index (BMI) and markers of eosinophilic inflammation in asthma Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014